Atlas Trials

Hypercholesterolaemia

41 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hypercholesterolaemia

RecordFirmDate
A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels (NCT04058834)Novo Nordisk A/S2019-08-20
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (NCT03510884)Sanofi2018-05-31
A Study of PCSK9 Inhibitor AK102 in Healthy Subjects (NCT04169386)Akeso2018-05-23
Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy (NCT03415178)Sanofi2018-03-29
Study to Evaluate the Safety of Repatha® in Pregnancy (NCT02906124)Amgen2017-01-12
An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (NCT02890992)Sanofi2016-09-15
Efficacy of Lactobacillus Mucosae DPC6426 on Blood-lipids (NCT07519967)University College Cork2016-05-30
Chart Review of Repatha® in Subjects With Hyperlipidaemia (NCT02770131)Amgen2016-05-04
Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin) (NCT02585778)Sanofi2015-10-23
The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome (NCT02065180)Universiteit Antwerpen2014-02-01
Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels (NCT01935674)Juan A. Arnaiz2013-09-01
Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin. (NCT01779687)Radboud University Medical Center2013-03-01
Rosuvastatin Calcium Bioequivalence Study - Fast (NCT01711749)GlaxoSmithKline2013-02-25
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH) (NCT01617655)Sanofi2012-06-01
Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values (NCT01483950)AstraZeneca2012-04-01
Acotral® Versus Zetia® Ezetimibe Bioequivalance Study. (NCT01597700)GlaxoSmithKline2012-01-13
Dose Effect of Limicol on (LDL)-Cholesterol Levels (NCT01354340)Lescuyer Laboratory2011-04-01
Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors (NCT01257971)AstraZeneca2011-01-01
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients (NCT00695539)AstraZeneca2007-12-01
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg (NCT00427960)AstraZeneca2006-12-01
TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060) (NCT00328523)Organon and Co2004-06-01
PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin. (NCT00329173)AstraZeneca2003-11-01
Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435) (NCT00653835)Organon and Co2003-09-01
Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women (NCT00163163)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2003-01-01
OLE Study to Evaluate Safety / Efficacy of ZD4522 (NCT00654303)AstraZeneca1999-08-01

Track Hypercholesterolaemia automatically

Every clearance here is in the API, with alerts when new ones post.